" class="no-js "lang="en-US"> NHS Comment on Milestone of 75% of All Adults Double-Jabbed in England - Medtech Alert
Sunday, September 24, 2023

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
NHS Comment on Milestone of 75% of All Adults Double-Jabbed in England | Pharmtech Focus

August 13 2021

NHS Comment on Milestone of 75% of All Adults Double-Jabbed in England

NHS comment as the latest vaccine statistics published today show that 75% of people aged 18 and older are now fully vaccinated with two doses in England.

Dr Nikita Kanani Medical Director for Primary Care and Deputy for the NHS Covid-19 Programme, said: “NHS staff have pulled out all the stops to get the lifesaving Covid jab to people as soon as possible and their exceptional hard work rolling out the biggest and fastest vaccination programme in history has meant that three quarters of all adults in England are now fully vaccinated, including 95 percent of people aged 50 and over.

“Getting the vaccine is the single most important step you can take to protect yourself and others, with hundreds of convenient vaccination sites across the country including pop up clinics in the park and at festivals and walk-in locations too and so if you haven’t already, I would urge you to come forward today and join the tens of millions of people who have already been vaccinated.”

People In This Post

Nikita Kanani

Nikita (Nikki) Kanani

Companies In This Post

NHS | Pharmtech Focus

NHS
  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients

    Clinical Trials

     Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS

    Clinical Trials

     Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board

    Appointments

     Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

    News

     Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic

    Clinical Trials

     Read more
More On